ClinConnect ClinConnect Logo
Search / Trial NCT06697418

The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients

Launched by RUIJIN HOSPITAL · Nov 17, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Peritoneal Dialysis Physical Activities Wristband Cardiovascular Risk Cognition

ClinConnect Summary

Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD), and cognitive impairment is also common in CKD patients. Previous studies have suggested an association between physical activity (PA) levels, CVD, and mild cognitive impairment. However, no relevant studies have been conducted in peritoneal dialysis (PD) patients, who are at high risk for both CVD and cognitive impairment. This study aims to measure the daily PA levels of PD patients using a wristband and analyze its impact on CVD and cognitive function in these patients.

The study co...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. 18 years old or above, under 75 years old
  • 2. Receiving peritoneal dialysis treatment in Ruijin hospital for more than three months
  • 3. Having the ability to walk independently
  • 4. Willing to accept relevant training and sign informed consent
  • Exclusion Criteria:
  • 1. Unable or unwilling to provide written informed consent;
  • 2. Unwilling to cooperate with regular follow-up or telephone follow-up;
  • 3. Evidence of liver damage (ALT, AST≥ 2 times the upper limit of normal);
  • 4. Patients with newly diagnosed malignant tumors in the past year or undergoing radiotherapy or chemotherapy;
  • 5. NYHA class III or IV congestive heart failure, myocardial infarction, stable or unstable angina;
  • 6. New-onset stroke (within the past 3 months, including cerebral hemorrhage and cerebral infarction);
  • 7. Severe mental illness or a diagnosis of dementia.

About Ruijin Hospital

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported